DE:C68 / Crescent Biopharma, Inc. - Net Long/Short Value

新月生物制药公司
DE ˙ DB ˙ US14888D2080
DE:C68 / Crescent Biopharma, Inc. - Net Long/Short Value
本页提供通过 13F 或 NPORT 申报的各机构持股的多空净值。为了计算净多空价值,我们将股票价值与看涨期权价值相加,再减去看跌期权价值。报告借入空头头寸的基金将以负数报告股票价值。净多头头寸将在净多/空一栏中显示正数,净空头头寸将在该栏中显示负值。
持有人 股票价值
($1000)
看涨期权价值
($1000)
看跌期权价值
($1000)
净多/空
($1000)
Soleus Capital Management, L.P.
Bvf Inc/il
Bank Of America Corp /de/
VR Adviser, LLC
Jefferies Financial Group Inc.
Fairmount Funds Management LLC
Frazier Life Sciences Management, L.P.
Driehaus Capital Management Llc
BlackRock, Inc.
Bnp Paribas Arbitrage, Sa
Deep Track Capital, LP
Wellington Management Group Llp
Barclays Plc
Morgan Stanley
Blackstone Group Inc
Royal Bank Of Canada
Commodore Capital Lp
UBS Group AG
Fmr Llc
Braidwell Lp
Perceptive Advisors Llc
Paradigm Biocapital Advisors LP
Adage Capital Partners Gp, L.l.c.
Raymond James Financial Inc
Group One Trading, L.p.
Tang Capital Management Llc
Affinity Asset Advisors, LLC
Boxer Capital Management, LLC
SBI Securities Co., Ltd.
Logos Global Management LP
Other Listings
US:CBIO US$14.24
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista